Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effect of Dymista on exercise-induced asthma in adolescents
NL-OMON20219Not yet recruiting
- Sponsor
- Stichting Pediatrisch Onderzoek Enschede
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma, allergic rhinitis (AR) and exercise-induced bronchospasm (EIB) comparing Dymista with Placebo (2 arms). Primary endpoints: Reduction in exercise-induced fall in FEV1 and Reduction in exercise-induced fall in MIF50. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
fluticasone propionate
03
Conditions
asthmaallergic rhinitis (AR)exercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NL-OMON20219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20219.